Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro

Cancer Science

Volumn 104, Issue 7, 2013, Pages 826-834

  Chen, Shaohong ^a   Wang, Zhiqiang ^a   Dai, Xinzhen ^a   Pan, Jianhua ^b   Ge, Juan ^a   Han, Xiqun ^a   Wu, Zijing ^a   Zhou, Xinhua ^a   Zhao, Tong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Division of Science and Technology Research   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 150; PROTEIN C MYB; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL DIFFERENTIATION; CELL SUBPOPULATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; ONCOGENE C MYB; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; TONSIL;

B-LYMPHOCYTES; BURKITT LYMPHOMA; CELL DIFFERENTIATION; CELL LINE, TUMOR; HERPESVIRUS 4, HUMAN; HUMANS; JURKAT CELLS; LYMPHOMA, B-CELL; MICRORNAS; PROTO-ONCOGENE PROTEINS C-MYB;

EID: 84880704991     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12156     Document Type: Article

References (56)

1. Burkitt D. A sarcoma involving the jaws in African children. Br J Surg 1958; 46: 218-23.
2. Leucci E, Onnis A, Cocco M et al. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression. Int J Cancer 2010; 126: 1316-26.
3. O'conor GT. Malignant lymphoma in African children II A pathological entity. Cancer 1961; 14: 270-83.
4. Stein H, Gerdes J, Mason DY. The normal and malignant germinal centre. Clin Haematol 1982; 11: 531-59.
5. Ferry JA. Burkitt's lymphoma: clinicopathologic features and differential diagnosis. Oncologist 2006; 11: 375-83.
6. Molyneux EM, Rochford R, Griffin B et al. Burkitt's lymphoma. Lancet 2012; 379: 1234-44.
7. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11: 441-50.
8. Jovanovic M, Hengartner MO. miRNAs and apoptosis: RNAs to die for. Oncogene 2006; 25: 6176-87.
9. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2007; 96(Suppl.): R40-4.
10. Neilson JR, Zheng GX, Burge CB, Sharp PA. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev 2007; 21: 578-89.
11. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 2008; 9: 839-45.
12. Havelange V, Garzon R. MicroRNAs: emerging key regulators of hematopoiesis. Am J Hematol 2010; 85: 935-42.
13. Ivey KN, Srivastava D. MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell 2010; 7: 36-41.
14. O'Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, Baltimore D. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc Natl Acad Sci USA 2010; 107: 14235-40.
15. Vasilatou D, Papageorgiou S, Pappa V, Papageorgiou E, Dervenoulas J. The role of microRNAs in normal and malignant hematopoiesis. Eur J Haematol 2010; 84: 1-16.
16. Monticelli S, Ansel KM, Xiao C et al. MicroRNA profiling of the murine hematopoietic system. Genome Biol 2005; 6: R71.
17. Xiao C, Calado DP, Galler G et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007; 131: 146-59.
18. Malumbres R, Sarosiek KA, Cubedo E et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 2009; 113: 3754-64.
19. Ghisi M, Corradin A, Basso K et al. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood 2011; 117: 7053-62.
20. Bezman NA, Chakraborty T, Bender T, Lanier LL. miR-150 regulates the development of NK and iNKT cells. J Exp Med 2011; 208: 2717-31.
21. Thomas MD, Kremer CS, Ravichandran KS, Rajewsky K, Bender TP. c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity 2005; 23: 275-86.
22. Di Lisio L, Sanchez-Beato M, Gomez-Lopez G et al. MicroRNA signatures in B-cell lymphomas. Blood Cancer J 2012; 2: e57.
23. Ballabio E, Mitchell T, van Kester MS et al. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood 2010; 116: 1105-13.
24. Watanabe A, Tagawa H, Yamashita J et al. The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 2011; 25: 1324-34.
25. Pereira DM, Rodrigues PM, Borralho PM, Rodrigues CM. Delivering the promise of miRNA cancer therapeutics. Drug Discov Today 2012; 18: 282-9.
26. Fazi F, Rosa A, Fatica A et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005; 123: 819-31.
27. Fazi F, Racanicchi S, Zardo G et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 2007; 12: 457-66.
28. Garzon R, Pichiorri F, Palumbo T et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 2007; 26: 4148-57.
29. De Marchis ML, Ballarino M, Salvatori B, Puzzolo MC, Bozzoni I, Fatica A. A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells. Leukemia 2009; 23: 856-62.
30. Wang XS, Gong JN, Yu J et al. MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood 2012; 119: 4992-5004.
31. Huang X, Zhou X, Wang Z et al. CD99 triggers upregulation of miR-9-modulated PRDM1/BLIMP1 in Hodgkin/Reed-Sternberg cells and induces redifferentiation. Int J Cancer 2011; 131: E382-94.
32. Klein U, Tu Y, Stolovitzky GA et al. Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci USA 2003; 100: 2639-44.
33. Zhang J, Jima DD, Jacobs C et al. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 2009; 113: 4586-94.
34. Lu J, Guo S, Ebert BL et al. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell 2008; 14: 843-53.
35. He L, Thomson JM, Hemann MT et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-33.
36. Chang TC, Yu D, Lee YS et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40: 43-50.
37. MacLennan IC. Germinal centers. Annu Rev Immunol 1994; 12: 117-39.
38. Cervero C, Escribano L, San MJ et al. Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia. Am J Hematol 1999; 60: 191-5.
39. Jourdan M, Caraux A, De Vos J et al. An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization. Blood 2009; 114: 5173-81.
40. Friend C, Scher W, Holland JG, Sato T. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci USA 1971; 68: 378-82.
41. Sachs L. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature 1978; 274: 535-9.
42. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980; 77: 2936-40.
43. Breitman TR, Collins SJ, Keene BR. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 1981; 57: 1000-4.
44. Taulli R, Bersani F, Foglizzo V et al. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest 2009; 119: 2366-78.
45. Bellan C, Lazzi S, Hummel M et al. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 2005; 106: 1031-6.
46. Lin YC, Kuo MW, Yu J et al. c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development. Mol Biol Evol 2008; 25: 2189-98.
47. Zhou L, Qi X, Potashkin JA, Abdul-Karim FW, Gorodeski GI. MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript. J Biol Chem 2008; 283: 28274-86.
48. Wu Q, Jin H, Yang Z et al. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun 2010; 392: 340-5.
49. Bian Z, Li L, Cui J et al. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis. J Pathol 2011; 225: 544-53.
50. Brennecke J, Stark A, Russell RB, Cohen SM. Principles of microRNA-target recognition. PLoS Biol 2005; 3: e85.
51. Ramkissoon SH, Mainwaring LA, Ogasawara Y et al. Hematopoietic-specific microRNA expression in human cells. Leuk Res 2006; 30: 643-7.
52. Zhang Y, Liu D, Chen X et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010; 39: 133-44.
53. Onnis A, Navari M, Antonicelli G et al. Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma. Blood. Cancer J 2012; 2: e84.
54. Ng SB, Yan J, Huang G et al. Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma. Blood 2011; 118: 4919-29.
55. Staudt LM, Dave S. The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol 2005; 87: 163-208.
56. Lin KI, Tunyaplin C, Calame K. Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol Rev 2003; 194: 19-28.